rabeprazole has been researched along with Inflammation in 7 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Son, M | 1 |
| Park, IS | 1 |
| Kim, S | 1 |
| Ma, HW | 1 |
| Kim, JH | 1 |
| Kim, TI | 1 |
| Kim, WH | 1 |
| Han, J | 1 |
| Kim, SW | 1 |
| Cheon, JH | 1 |
| Xia, Q | 1 |
| Lyu, C | 1 |
| Li, F | 1 |
| Pang, B | 1 |
| Guo, X | 1 |
| Ren, H | 1 |
| Xing, Y | 1 |
| Chen, Z | 1 |
| Manabe, N | 1 |
| Yamamoto, T | 1 |
| Matsusaki, M | 1 |
| Akashi, M | 1 |
| Haruma, K | 1 |
| Takeda, N | 1 |
| Takemura, M | 1 |
| Kanemitsu, Y | 1 |
| Hijikata, H | 1 |
| Fukumitsu, K | 1 |
| Asano, T | 1 |
| Yamaba, Y | 1 |
| Suzuki, M | 1 |
| Kubota, E | 1 |
| Kamiya, T | 1 |
| Ueda, T | 1 |
| Niimi, A | 1 |
| Nykula, TD | 1 |
| Furleta, VV | 1 |
| Oguro, M | 1 |
| Koike, M | 1 |
| Ueno, T | 1 |
| Asaoka, D | 1 |
| Mori, H | 1 |
| Nagahara, A | 1 |
| Uchiyama, Y | 1 |
| Watanabe, S | 1 |
| Suzuki, H | 1 |
| Miyazawa, M | 1 |
| Nagahashi, S | 1 |
| Sato, M | 1 |
| Bessho, M | 1 |
| Nagata, H | 1 |
| Miura, S | 1 |
| Ishii, H | 1 |
7 other studies available for rabeprazole and Inflammation
| Article | Year |
|---|---|
Novel Potassium-Competitive Acid Blocker, Tegoprazan, Protects Against Colitis by Improving Gut Barrier Function.
Topics: Animals; Benzene Derivatives; Colitis; Dysbiosis; Imidazoles; Inflammation; Inflammatory Bowel Disea | 2022 |
Candidate Drugs Screening for Behcet's Disease Based on Bioinformatics Analysis and Mouse Experiments.
Topics: Animals; Behcet Syndrome; Computational Biology; Cytokines; Gene Expression Profiling; Inflammation; | 2022 |
Measurement of low-grade inflammation of the esophageal mucosa with electrical conductivity shows promise in assessing PPI responsiveness in patients with GERD.
Topics: Animals; Caco-2 Cells; Electric Conductivity; Esophageal Mucosa; Esophageal pH Monitoring; Female; G | 2021 |
Effect of anti-reflux treatment on gastroesophageal reflux-associated chronic cough: Implications of neurogenic and neutrophilic inflammation.
Topics: Adult; Aged; Chronic Disease; Cough; Female; Gastroesophageal Reflux; Humans; Inflammation; Leukocyt | 2020 |
[Rationale for improved treatment of ulcerative disease complicated by chronic pyelonephritis].
Topics: Aged; Amoxicillin; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Diet; Female; Helicobacter In | 2013 |
Dissociation and dispersion of claudin-3 from the tight junction could be one of the most sensitive indicators of reflux esophagitis in a rat model of the disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Claudin-1; Claudin-3; Claudin-4; Disease Models, A | 2011 |
Rabeprazole treatment attenuated Helicobacter pylori-associated gastric mucosal lesion formation in Mongolian gerbils.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Analysis of Variance; Animals; Anti-Ulcer Agents; Benzimida | 2003 |